Psychedelics are achieving breakthrough outcomes in the kinds of healing the world desperately needs. COVID-19 only makes those needs more urgent. In the coming years psychedelic treatment may transform mental health and reach millions of suffering people.
The business side of working with non-ordinary states of consciousness raises
unique ethical questions. Unethical action could not only harm participants, but given the history and legal standing of psychedelics, could also lead to debilitating setbacks for the field. By centering integrity in the professional culture of the field, we can build a future where safe and legal contexts for the beneficial uses of psychedelics are available at scale.